MIM to Present at UBS Global Healthcare Services Conference

    Business Editors
    UBS Global Healthcare Services Conference 2005

    ELMSFORD, N.Y.--(BUSINESS WIRE)--Feb. 2, 2005--MIM Corporation (NASDAQ: MIMS) (CBOE:OQX) (PCX:OQX), a pharmaceutical healthcare organization, today announced that it will present at the UBS Global Healthcare Services Conference on February 14-16, at The Plaza in New York City.
    MIM Chairman and Chief Executive Officer, Richard H. Friedman and Chronimed Chairman and Chief Executive Officer, Henry F. Blissenbach will jointly present their strategic direction for the combined company on February 14, at 4:30 PM ET.
    Investors may access a webcast of the presentation on the MIM Corporation website, www.mimcorporation.com, on the presentations page of the investor information section.

    MIM Corporation (www.mimcorporation.com) is a pharmaceutical healthcare organization delivering innovative pharmacy benefit and healthcare solutions that provide results beyond expectations. We excel by harnessing our clinical expertise, sophisticated data management, and therapeutic fulfillment capability, and combine it with our dedicated, responsive team of professionals that understands our partners' needs. The result is cost-effective solutions enhancing the quality of patient life.

    This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.

--30--MW/ny*

CONTACT: MIM Corporation Barry A. Posner, 914-460-1638 bposner@mimcorporation.com or The Anne McBride Co. Investor Relations Rachel Levine, 212-983-1702 x 207 rlevine@annemcbride.com

KEYWORD: NEW YORK TRACK INDUSTRY KEYWORD: PHARMACEUTICAL BIOTECHNOLOGY TRADESHOW SOURCE: MIM Corporation

Copyright Business Wire 2005